In vitro antifungal activity of naftifine hydrochloride against dermatophytes

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 9, 2013, Pages 4369-4372

  Ghannoum, M ^a   Isham, N ^a   Verma, A ^b   Plaum, S ^b   Fleischer Jr , A ^b   Hardas, B ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b Merz Pharmaceuticals LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NAFTIFINE;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; ARTICLE; COLONY FORMING UNIT; DERMATOPHYTE; DRUG EXPOSURE; EPIDERMOPHYTON FLOCCOSUM; IN VITRO STUDY; MICROSPORUM CANIS; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM; TRICHOPHYTON TONSURANS;

ALLYLAMINE; ANTIFUNGAL AGENTS; CULTURE MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIDERMOPHYTON; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROSPORUM; TRICHOPHYTON;

EID: 84882417054     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01084-13     Document Type: Article

References (21)

1. Havlickova A, Czaika VA, Friedrich M. 2008. Epidemiological trends in skin mycoses worldwide. Mycoses 51(Suppl 4):2-15.
2. Aly R. 1994. Ecology and epidemiology of dermatophyte infection. J. Am. Acad. Dermatol. 31(3 Pt 2):S21-S25.
3. Legge BS, Grady JF, Lacey AM. 2008. The incidence of tinea pedis in diabetic versus nondiabetic patients with interdigital macerations: a prospective study. J. Am. Podiatr. Med. Assoc. 98:353-356.
4. Panackal AA, Halpern EF, Watson AJ. 2009. Cutaneous fungal infections in the United States: analysis of the National Ambulatory Medical Care Survey (NAMCS) and National Hospital Ambulatory Medical Care Survey (NHAMCS), 1995-2004. Int. J. Dermatol. 46:704-712.
5. Stock I. 2008. Antimycotic therapy of tinea pedis and other foot mycoses. Med. Monatsschr. Pharm. 31:247-256.
6. Delgado Florencio V, Abad Romero-Baimas J. 1999. On the epidemiology of dermatophytoses in Granada (Andalousia, Spain). Rev. Iberoam. Micol. 16:53-56. (In Spanish.)
7. Seebacher C, Bouchara JP, Mignon B. 2008. Updates on the epidemiology of dermatophyte infections. Mycopathologia 166:335-352.
8. Venugopal PV, Venugopal TV. 1994. Antidermatophytic activity of allylamine derivatives. Indian J. Pathol. Microbiol. 37:381-388.
9. Birnbaum JE. 1990. Pharmacology of the allylamines. J. Am. Acad. Dermatol. 23(4 Pt 2):782-785.
10. Monk JP, Brogden RN. 1991. Naftifine. A review of its antimicrobial activity and therapeutic use in superficial dermatomycoses. Drugs 42: 659-672.
11. Maertens JA. 2004. History of the development of azole derivatives. Clin. Microbiol. Infect. 10(Suppl 1):1-10.
12. Andrade TS, Castro LG, Nunes RS, Gimenes VM, Cury AE. 2004. Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents. Mycoses 47:216-221.
13. Gupta AK, Kohli Y. 2003. Evaluation of in vitro resistance in patients with onychomycosis who fail antifungal therapy. Dermatology 207:375-380.
14. Ghannoum MA, Chaturvedi V, Espinel-Ingroff A, Pfaller MA, Rinaldi MG, Lee-Yang W, Warnock DW. 2004. Intra-and interlaboratory study of a method for testing the antifungal susceptibilities of dermatophytes. J. Clin. Microbiol. 42:2977-2979.
15. CLSI. 2008. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard, 2nd ed. CLSI document M38-A2. CLSI, Wayne, PA.
16. Canton E, Peman J, Viudes A, Quindos G, Gobernado M, Espinel-Ingroff A. 2003. Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species. Diagn. Microbiol. Infect. Dis. 45:203-206.
17. Ghannoum MA, Isham N. 2007. Voriconazole and caspofungin cidality against non-albicans Candida species. Infect. Dis. Clin. Pract. 15:250-253.
18. Klepser ME, Ernst EJ, Lewis RE, Ernst ME, Pfaller MA. 1998. Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods. Antimicrob. Agents Chemother. 42:1207-1212.
19. Georgopoulos A, Petranyi G, Mieth H, Drews J. 1981. In vitro activity of naftifine, a new antifungal agent. Antimicrob. Agents Chemother. 19: 386-389.
20. Petranyi G, Ryder NS, Stütz A. 1984. Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase. Science 224:1239-1241.
21. Bradley MC, Leidich S, Isham N, Elewski BE, Ghannoum MA. 1999. Antifungal susceptibilities and genetic relatedness of serial Trichophyton rubrum isolates from patients with onychomycosis of the toenail. Mycoses 42(Suppl 2):105-110.